Michael Abern

Check out the data from PSMAfore biomarker analysis: Huge prognostic significance in baseline and 6-week on treatment ctDNA levels and outcomes. Adds to PSA 50 response as well. Could guide future management in this earlier disease setting. ⁦⁦⁦@DukeCancer⁩ #GU25

Our @DukeUrology team looking fresh after completing the Shakori40 trail ultra marathon relay! Best quote of the day : “Perfect day aside from all of the running “ 😅

Our oncologic surgeons at @DukeUrology are looking forward to the SUO annual meeting. We are excited to discuss our fellowship program with interested resident applicants. DM me or @AnkeetShahMD to set up a meeting at SUO…

@ChapinMD Difference between palpable cT3 and MRI “capsular abutment or bulging” cT3. I’m reluctant to label cT3 based on MR alone .

Case of the day. 51 yo with cT3aN0M0 on CT/BS/MRI, GG5, PSA 12, IIEF-23, AUA-SI of 6 PSMA PET w/left obturator 6mm LN with SUV of 7, Liver at 8. Treatment choice for uros:(separate poll for Rad/Oncs)

The Duke SUO Fellowship interviews will be held on campus on Friday April 14th. Application deadline is Friday February 17th.

@DukeHealth @DukeSurgery @DukeUrology @DukeHospital @DukeGUCancer I’m grateful to our clinical research and robotic surgery team for getting us started! Just the beginning….

Congratulations to Dr. Michael Abern & colleagues for this technological milestone. @DukeSurgery | @DukeUrology | @DukeHospital | @DukeGUCancer

@BrantInman 2: assuming you mean phase 3 based on promising phase 1/2

@BrantInman @DukeGUCancer @AmCollSurgeons @CMSGov Yes. Trying to limit outpatient radiology but balance with risk. Staging and surveillance and expected progression can be gray areas. Most agree on what is emergent.

@jimhumd @nytimes I’ll go urologist = TE. Versatile, tough, and the obvious DRE ref 🤷‍♂️

@BrantInman @DukeGUCancer @AmCollSurgeons @CMSGov Thanks. We put together a surgical acuity matrix for all urologic surgery. My next challenge is trying to categorize cancer imaging. Have you guys tackled it yet ?

@RealProstateDoc If it’s clear cell and the distal pancreas or SMA are involved could try to downstage with IOT (#3). If not just resect

Twitter Tumor Board Healthy 63 yo. Remote R. nephrectomy adrenalectomy for RCC. Remote lung mets x 2 Rx with metastectomy plus INF-a/IL-2. NOW THIS - symptomatic. Assuming Bx+ RCC, what would u do? 1. Resection 2. Systemic therapy 3. Systemic therapy and Sx if response

Excellent visiting professor lecture by Dr Skinner on the nuances of the AUA MIBC guidelines @UICUrol

@PatrickSelph @SocietyGURS @SUO_YUO yes - that’s what I do. however, I don’t have data to support it. perhaps a higher parastomal hernia rate?

What’s been your experience with ileal conduit through fascia only on same side of VRAM during pelvic exent? Do you put both ostomies in same side to avoid conduit through side without muscle? @SocietyGURS @SUO_YUO

@uroegg @DanLinMD @DrHWoo agree with @uroegg . my colleagues have been using the procedure on AS and I have had no issues during RP

@DanLinMD Initially communicated with UroLift and prostate guru @DrHWoo. Have done 2: total non-issue

#BallingforHealth this morning, @DrWinnUIC encourages young men to talk with their families about their health this holiday season. #uic3on3 #menshealth @djpatxkl @thisisUIC @michaelabern @UICUrol @UIHealth pic.twitter.com/hlbIFPtwVk

So close to 500 followers - currently sitting at 496. Do follow us for updates on the latest research papers on prostate cancer and prostatic diseases

@gupta_go @vourganti @arosenkrantzmd @radiolobt I agree re #CAD. I think we can intelligently design and optimize quicker “screening” MR protocols that reduce magnet time

@vourganti @arosenkrantzmd @radiolobt @vourganti it’s a supply/demand issue. I think once rapidly adopted, access/cost will resolve. Certainly we will get better at choosing who needs an MRI as well. But #CAD will be key

This is what scares me re: #Precision trl and prebiopsy mpMRI. We are talking about 500k-1M scans/yr in USA. @arosenkrantzmd published that we have <40k radiologists, only a small fraction of whom can read prostate MR. Access will be a MAJOR issue. We will need #CAD! @radiolobt? twitter.com/DavidBluemke/s…

CHEERS @LondonProstate1. Also very much acknowledged your foundation work in this area Hashim. Two great studies. We don’t need any more evidence. These two papers will also enable reimbursement for MRI around the world #EAU18 twitter.com/londonprostate…

POUT phase 3 study results : Afrer neph U for UTUC: adjuvant platinum chemotherapy improves disease and met free survival #EAU18

At the EAU International Friendship Dinner #EAU18 @PatrickSelph @qdtrinh